Methods for optimizing treatment of proliferative diseases by imatinib receptor tyrosine kinase kit
- 专利权人:
- NOVARTIS AG
- 发明人:
- YANFENG WANG,ELISABETH WEHRLE
- 申请号：
- BRPI0906504
- 公开号：
- BRPI0906504A2
- 申请日:
- 2009.01.21
- 申请国别(地区):
- BR
- 年份:
- 2015
- 代理人:
- 摘要：
- The invention relates to a method of treating proliferative diseases mediated by the tyrosine kinase receptor KIT, in particular GIST, in a human patient population.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Methods for optimizing the treatment with proliferative diseases imatinib mediated by the tyrosine kinase receptor KIT
- METHOD OF OPTIMIZING THE TREATMENT OF PROLIFERATIVE DISEASES MEDIATED BY THE TYROSINE KINASE RECEPTOR KIT WITH IMATINIB
- Methods for optimizing the treatment with proliferative diseases imatinib mediated by the tyrosine kinase receptor KIT
- Method of Optimizing the treatment of Proliferative Diseases Mediated by the Tyrosine Kinase Receptor KIT with Imatinib
- Method of Optimizing the treatment of Proliferative Diseases Mediated by the Tyrosine Kinase Receptor KIT with Imatinib
